C5 CEE Private Equity Forum Event Summary
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Media Influence Matrix Slovakia
J A N U A R Y 2 0 2 0 MEDIA INFLUENCE MATRIX: SLOVAKIA Government, Politics and Regulation Author: Marius Dragomir 2nd updated edition Published by CEU Center for Media, Data and Society (CMDS), Budapest, 2020 About CMDS About the author The Center for Media, Data and Society Marius Dragomir is the Director of the Center (CMDS) is a research center for the study of for Media, Data and Society. He previously media, communication, and information worked for the Open Society Foundations (OSF) policy and its impact on society and for over a decade. Since 2007, he has managed practice. Founded in 2004 as the Center for the research and policy portfolio of the Program Media and Communication Studies, CMDS on Independent Journalism (PIJ), formerly the is part of Central European University’s Network Media Program (NMP), in London. He School of Public Policy and serves as a focal has also been one of the main editors for PIJ's point for an international network of flagship research and advocacy project, Mapping acclaimed scholars, research institutions Digital Media, which covered 56 countries and activists. worldwide, and he was the main writer and editor of OSF’s Television Across Europe, a comparative study of broadcast policies in 20 European countries. CMDS ADVISORY BOARD Clara-Luz Álvarez Floriana Fossato Ellen Hume Monroe Price Anya Schiffrin Stefaan G. Verhulst Hungary, 1051 Budapest, Nador u. 9. Tel: +36 1 327 3000 / 2609 Fax: +36 1 235 6168 E-mail: [email protected] ABOUT THE MEDIA INFLUENCE MATRIX The Media Influence Matrix Project is run collaboratively by the Media & Power Research Consortium, which consists of local as well as regional and international organizations. -
Penta Holding Limited /Annual Report 2007
Penta Holding Limited / Annual Report 2007 It doesn´t take just seeding – it takes more to have a good harvest. We know how. With the right care a single seed can be grown into a strong plant and the whole fi eld can fl ourish from its fruitage. Contents 04 Tombstones 06 Financial Highlights 08 Our Profi le 10 Director’s Statement 14 Holding Structure 16 Partners 18 Operational Structure 20 Penta’s Key Investments 30 Management Discussion & Analysis 40 Penta Holding Limited 50 Penta Investments Limited 60 Contacts Completed Investments ADAST, a.s. Letisko Košice, a.s. Slovenské lodenice, a.s. manufacturing transport manufacturing Czech Republic Slovakia Slovakia Česká konsolidační agentura Reštitučný investičný fond, a.s. Slovnaft, a.s. fi nancial investment fund oil and gas Czech Republic Slovakia Slovakia Severomoravské vodovody Drôtovňa Hlohovec, a.s. a kanalizace Ostrava a.s. Tento, a.s. manufacturing utilities manufacturing Slovakia Czech Republic Slovakia Elektrovod Bratislava, a.s. Slovenská plavba a prístavy, a.s. VÚB Kupón utilities transport investment fund Slovakia Slovakia Slovakia Chemolak, a.s. Slovenská poisťovňa, a.s. manufacturing insurance Slovakia Slovakia Real Estate Projects Digital Park, a.s. The Port, a.s. real estate real estate Slovakia Slovakia Investments in Progress Mobile Entertainment Company, a.s./ AERO Vodochody a.s. MOBILKING VSŽ - slovenské investičné družstvo aerospace telecommunications metal industry Czech Republic Poland Slovakia Alpha Medical Ventures, s.r.o. MobilKom, a.s./U:fon ZSNP, a.s. health care telecommunications metal industry Slovakia Czech Republic Slovakia AVC, a.s. PM Zbrojníky, a.s. Žabka manufacturing food processing retail Slovakia Slovakia Poland, Czech Republic Dr. -
Startup Valuation THESIS V.35 (REVISADA)
UNIVERSIDADE DE SÃO PAULO FACULDADE DE ECONOMIA, ADMINISTRAÇÃO E CONTABILIDADE PROGRAMA DE PÓS-GRADUAÇÃO EM ADMINISTRAÇÃO Jose Roberto Securato Junior CLASSIFICATION, INVESTMENT SELECTION, AND VALUATION OF NEW VENTURE AND STARTUP COMPANIES CLASSIFICAÇÃO, SELEÇÃO DE INVESTIMENTOS, E VALUATION DE NEW VENTURES E STARTUPS Versão Corrigida (versão original disponível na Biblioteca da Faculdade de Economia, Administração e Contabilidade) São Paulo 2020 1 Prof. Dr. Vahan Agopyan Reitor da Universidade de São Paulo Prof. Dr. Fabio Frezatti Diretor da Faculdade de Economia, Administração e Contabilidade Prof. Dr. Moacir de Miranda Oliveira Junior Chefe do Departamento de Administração Prof. Dr. Eduardo Kazuo Kayo Coordenador do Programa de Pós-Graduação em Administração 2 Jose Roberto Securato Junior CLASSIFICATION, INVESTMENT SELECTION, AND VALUATION OF NEW VENTURE AND STARTUP COMPANIES Tese apresentada ao Programa de Pós- Graduação em Administração do Departamento de Administração da Faculdade de Economia, Administração e Contabilidade da Universidade de São Paulo, como requisito parcial para obtenção do título de Doutor em Ciências. Orientador: Prof. Dr. Jose Roberto Ferreira Savoia Versão Corrigida (versão original disponível na Biblioteca da Faculdade de Economia, Administração e Contabilidade) São Paulo 2020 3 4 Excellence precedes success 5 RESUMO Esta tese examina como a seleção de investimentos e a avaliação econômico-financeira de new ventures e startups variam ao longo do ciclo de vida destas companhias. A abordagem de pesquisa foi estruturada em 3 fases: i) revisão da literatura em new ventures e startups, ii) um questionário para 105 investidores qualificados e entrevistas públicas sobre perspectivas dos investidores, e iii) modelagem do retorno esperado ao longo do ciclo de vida das new ventures e startups com base em regressões robustas. -
Pharma Drives Economic Growth in Central Europe
What the doctor ordered: Pharma drives economic growth in Central Europe Leveraging location, low costs, and strong legacy companies with a skilled labour pool, the pharmaceutical industry is a quiet success story in Central and Eastern Europe (CEE). The sector is a major contributor to exports and R&D spending in several countries, and has become a magnet for M&A deals in recent years. International pharmaceutical companies have a strong manufacturing presence across the CEE region, producing and exporting a wide range of products. US multinational Teva, for example, gained CEE assets – including two generics factories in Bulgaria and oncology drugs facility in Romania – when it acquired Allergan’s Actavis Generics in 2016. Meanwhile, Sanofi announced earlier this year that it would carve out its active pharmaceutical ingredient (API) business as a standalone company, creating the world’s second-largest API manufacturer.[1]Its production facilities will include a plant in Ujpest, Hungary. Basel-based Novartis has invested nearly €2bn in Slovenia since 2003, largely through its generics and biosimilars business Sandoz, which has four locations in the country. And in 2019 Sandoz itself announced a deal for the global commercialisation and distribution of a biosimilar to combat multiple sclerosis, to be developed and manufactured by Gdansk-based Polphama Biologics.[2] An export edge Generics manufacturing in particular relies on three factors: low costs, reliable supply chains, and a skilled workforce – including a regulatory team able to spot products coming off patent. CEE has all these factors, making it a prime manufacturing location for the rest of Europe and beyond. -
Boaml PE Team Spins out Newquest Capital Partners to Focus on Direct Secondaries in Asia Via Its $400 Million Fund
FUNDS [email protected] BoaML PE team spins out NewQuest Capital Partners to focus on direct secondaries in Asia via its $400 million fund AS WESTERN INVESTMENT BANKS COME Asia, we’re talking only about 10% and that’s cycle for some of the assets BoaML had held under increasing pressure to minimize their largely limited to the buy-out markets of Japan, in its portfolio for the past years. Massara risk – and have thus shed their alternative asset Korea and Australia. We think that it is largely notes that the "rm may announce its "rst exits investment units – Bank of America Merrill Lynch due to the fact that there are a limited number of in the coming months, and as well as new (BoaML) has taken a unique stance in the spin buyers focused on that part of the market” investments. o! of its private equity business, seeing its head Massara explains that the size of Asia’s un- “The fund currently has $400 million, of which professionals launch an independent, direct exited deal market is roughly US$150 billion. a signi"cant amount of that is dry powder for secondaries-focused "rm backed by the new investments,” says Jason Sambanju, region’s top LPs. Co-Head of Paul Capital Asia, NewQuest’s NewQuest Capital Partners, backed by cornerstone LP. “One way to tap into more a consortium consisting of Paul Capital, capital is thru NewQuest’s existing LPs. HarbourVest Partners, LGT Capital Partners So when the opportunity to increase the and Axiom Asia, has acquired “substantially fund size arises, we can easily step up to all” of BoaML’s non-real estate private put more money to work.” equity portfolio in Asia, launching the The BoaML-cum-NewQuest team $400 million NewQuest Asia Fund I, L.P., began discussions with Paul Capital, to manage the assets. -
Secondary Market Poised to Lift
20SecondaI BUYOUTS I December 13.2010 vnnv.buyoutsnews.com arket Poised To Lift Off ByTom Stein Sellers Proliferate Secondary buyers have been predicting big Indeed, it’s no secret that financial insti tutions have their backs to the wall, They things for their market for some time. Now it are under increasing regulatory pressure to finally seems to be coming to pass. restrict their exposure to private equity. Governments and financial regulators are hammering out new rules, including Basel III and the Volcker Rule in the United States, After a dismal 2009, in which only $8 bil ing to investors a potentially cheaper and which will make private equity investing a lion worth of private equity assets were trad more liquid way to get exposure to private lot less attractive for financial institutions ed on the secondary market, 2010 is shaping equity. For LPs, an active market means an and possibly even prevent them from creat up to be a record year. Total volume for the opportunity to snap up some bargains, ing their own private equity vehicles. year is expected to reach $25 billion, easily either by directly purchasing secondary This year saw the start of some of that surpassing the previous record of $15 billion positions or by investing in secondary funds. unwinding, with AXA PrIvate EquIty pur set in 2008, according to private equity advi What is the bullish case for the second chasing part of Bank ot America’s private sory firm Triago. ary market? For starters, Richard Lichter, equity portfolio for $1.9 billion. The deal For investors like David de Weese. -
PRESS RELEASE Goetzpartners Advised Penta Exclusively in the Acquisition of Lloyds Pharmacies and a Pharmaceutical Distributor in the Czech Republic
PRESS RELEASE goetzpartners advised Penta exclusively in the acquisition of Lloyds pharmacies and a pharmaceutical distributor in the Czech Republic Penta Investments, the Central European investment group, has agreed with Celesio AG to acquire its Lloyds pharmacy chain and Gehe wholesale distributor. The purchase price reached EUR 84.5 million. Lloyds operates 55 pharmacies and is the third largest pharmacy chain in the Czech Republic, while Gehe is the fourth biggest wholesale pharmaceutical distributor in the Czech Republic. The transaction is subject to the Czech antitrust authority clearance. goetzpartners acted as exclusive financial advisor to Penta in this transaction. The Lloyds pharmacies will be integrated into Ceska lekarna, a.s, which operates the Dr. Max pharmacy chain on the Czech market. "We are consolidating pharmacies in Central Europe through Dr. Max and its local platforms. The Lloyds pharmacies and an important distributor Gehe have therefore been a very reasonable target for us. We strongly believe that market consolidation in the pharmacy sector significantly contributes to better quality and accessibility of services for patients," said Václav Jirků, Investment Director at Penta. "The integration of Lloyds pharmacies will support our efforts to become the most accessible pharmacy chain in terms of price and location, while the Gehe acquisition is an opportunity to implement our successful Dr. Max business model to the wholesale market. We plan to attract Gehe's independent clients with strategies similar to those we used in the retail market, namely competitive price and services," said Pavel Vajskebr, Dr. Max's CEO. “By this acquisition Penta significantly contributes to strategically improve pharmaceutical distribution in Central Europe, said Dr. -
D6-2 Slovakia
EU Grant Agreement number: 290529 Project acronym: ANTICORRP Project title: Anti-Corruption Policies Revisited Work Package: WP 6 Media and corruption Title of deliverable: D 6.2 Case studies on corruption involving journalists Case studies on corruption involving journalists: Slovakia Due date of deliverable: 31 August, 2016 Actual submission date: 31 August, 2016 Author: Andrej Školkay (SKAMBA) Contributors: Alena Ištoková, Ľubica Adamcová, Dagmar Kusá, Juraj Filin, Martin Matis, Veronika Džatková, Ivan Kuhn, Gabriela Mezeiová and Silvia Augustínová Organization name of lead beneficiary for this deliverable: UNIPG, UNIVERSITÀ DEGLI STUDI DI PERUGIA Project co-funded by the European Commission within the Seventh Framework Programme Dissemination level PU Public X PP Restricted to other programme participants (including the Commission Services) RE Restricted to a group specified by the consortium (including the Commission Services) Co Confidential, only for members of the consortium (including the Commission Services) This project has been supported also by the Slovak Research and Development Agency DO7RP-0039-11 The information and views set out in this publication are those of the author(s) only and do not reflect any collective opinion of the ANTICORRP consortium, nor do they reflect the official opinion of the European Commission. Neither the European Commission nor any person acting on behalf of the European Commission is responsible for the use which might be made of the following information. 1 CONTENTS 1. Introduction p. 3 2. Case study 1: Can a “Lone Wolf” quasi-investigative journalist substitute p. 9 low functionality of the law enforcing system? 3. Case study 2: “Dangerous liaisons” between politicians and journalists in the context p. -
Brief Vorlage
Press release The Award Ceremony „Gutmann Awards for the most outstanding Family Business in CEE“ 2nd Gutmann Family Business Owners Day Gutmann Award for the most outstanding Family Business in Ukraine goes to Camion Oil Professor John A. Davis Harvard Business School, Boston, Olga Gutsal Camion Oil Ukraine, Gordian F. Gudenus Partner Bank Gutmann (Vienna, October 23rd, 2015) The 2nd Gutmann Family Business Owners Day brought together over 100 owners of leading Family Businesses from nine Central and Eastern European countries and two of the world’s leading Family Business Schools to an exclusive gathering at Bank Gutmann’s headquarter in Vienna. The Family Business Owners Day focused on the key challenges facing Family Businesses in CEE today: Innovation and the transition to the next generation. The Winner of the Gutmann Award for the Best Family Business in Ukraine is the company Camion Oil. A further highlight of the Family Business Owners Day was the Award Ceremony celebrating the winners of “The Gutmann Award for the Most Outstanding Family Businesses in CEE 2015” Bank Gutmann’s 2nd Family Business Owners Day (FBO-Day) has assembled over 100 owners of leading Family Businesses (FB’s) from nine Central and Eastern European countries in an exclusive gathering at Bank Gutmann’s headquarter in Vienna’s central Schwarzenbergplatz. The topics of the FBO-Day were presented by owners of prominent multigenerational European family businesses from Austria and the Netherlands and senior professors from the world’s leading business schools, Harvard Business School in Cambridge, USA and IESE Business School in Barcelona as key speakers. -
The Gorilla Case in Slovakia
Středoevropské politické studie / Central European Political Studies Review www.journals.muni.cz/cepsr Ročník XX (2018), Číslo 2, s. 182–203 / Volume XX (2018), Issue 2, pp. 182–203 (c) Mezinárodní politologický ústav / International Institute of Political Science DOI: 10.5817/CEPSR.2018.2.182 Partial state capture by a single oligarchic group: The Gorilla Case in Slovakia ANDREJ ŠKOLKAY1 Abstract: The article discusses the Gorilla case, an officially still-contested partial state capture by a single local oligarchic group, in line with the (partial) Elite Cartels corruption pattern in Slovakia. Due to the manner in which evidence, although considered unofficial, was made available, this case illustrates secret political and business processes during partial state capture. The initial absence of the case in public, political, and academic discourses, suggests that state capture can be present and operate undetected for a long time. This study also shows that in-depth analysis of the Gorilla case was avoided by both domestic and international political scientists, despite its paramount practical and theoretical importance. This, in turn, reflects a methodological capture of political science. Consequently, this article disentangles the complexities of the Gorilla case and lays down the foundation for further studies. Specifically, it highlights the need for more careful research, terminological precision in both theory- building and empirical findings on state and media capture based on case studies, as well as re- assessment of the methodology of political sciences used in these research areas. Keywords: Gorilla, Slovakia, Oligarchs, Corruption, State Capture, Intelligence Services, Wiretapping 1. Introduction The Gorilla case2, an alleged grand corruption case, had its importance downplayed by state authorities and the media (the latter in part being unaware of it), until public demonstrations flooded the streets of the capital of Slovakia a few years later. -
Summary of Alternative Investment Vehicle (AIV) Fees
Summary of Alternative Investment Vehicle (AIV) Fees, Expenses and Carried Interest Reported Pursuant to California Government Code Section 7514.7 (AB 2833) For the period July 1, 2016 through June 30, 2017 (Fiscal Year 2017) Fees and Expenses SDCERA's Pro-rata SDCERA's Pro-rata Share of Paid by SDCERA SDCERA's Pro-rata Share Share of Carried Aggregate Fees and Expenses Gross Internal Directly to the AIV, of Fees and Expenses Paid Interest Distributed Paid by the AIV's Portfolio Rate of Return Net Internal Rate Fund Manager or from the AIV to the Fund to the Fund Manager Companies to the Fund (IRR) Since of Return (IRR) Related Parties Manager or Related Parties or Related Parties Manager or Related Parties Inception3 Since Inception Section 7514.7 (d)(1)1 Expenses $173,226 $0 $0 $0 - - 2 Section 7514.7 (d)(2) Expenses $35,650,064 $3,524,917 $28,455,935 $1,250,127 -8.1% Total $35,823,290 $3,524,917 $28,455,935 $1,250,127 Section 7514.7 Expenses by Investment Category Private Equity $11,217,997 $1,194,294 $13,625,045 $1,001,618 - 9.9% Private Real Assets $9,393,188 $975,817 $5,588,021 $202,200 - 6.9% Private Credit $1,752,057 $745,955 $477,455 $45,740 - 3.0% Real Estate $7,450,301 $428,754 $8,681,193 $569 - 7.6% Alternative Fund Structures $6,009,748 $180,095 $84,221 $0 -- Total $35,823,290 $3,524,917 $28,455,935 $1,250,127 1 From January 1, 2017 through June 30, 2017, SDCERA entered into one contract in an alternative investment vehicle (Public Pension Capital, LLC) and made no new capital commitments into existing alternative investment vehicles. -
UBS Private Equity Secondary Market Review.Pdf
UBS Private Equity Secondary Market Review UBS Private Funds Group June—2011 UBS Private Funds Group Secondary Market Review The UBS Private Funds Group’s Secondary Advisory Practice was launched in 2004 with the mandate to provide the highest quality sell- side advice to owners of private equity portfolios. In the current installment of this series, UBS provides a comprehensive review of secondary market activity in 2010 and the first quarter of 2011 and highlights key issues and trends that will impact the secondary market in 2011. Our perspective is unique within the secondary market, based not only on our experience as a leading placement agent and secondary advisor, but also as a seller in the structuring and execution of UBS’s own $1.3 billion secondary transaction in 2003.1 To date, UBS has advised on and executed over $24 billion of secondary transactions and has established itself as a market leading advisor.2 Review of the Secondary Market—2010 Market Environment Secondary volume rebounded to record levels in 2010, totaling approximately $22 billion which represented a 132% increase as compared to 2009 levels ($9.5 billion).3 The combination of improved capital market conditions and strong levels of available capital resulted in a dramatic improvement in the pricing environment during the first quarter of 2010, while increased regulatory pressure crystallized financial institutions’ intention to sell risk assets. Following a somewhat slow start to the beginning of 2010, the year began to pick up momentum following the announcement of Bank of America’s $1.9 billion transaction and RBS’ €400 million transaction.